Literature DB >> 8175135

Acute hepatic and renal toxicity from low doses of acetaminophen in the absence of alcohol abuse or malnutrition: evidence for increased susceptibility to drug toxicity due to cardiopulmonary and renal insufficiency.

H L Bonkovsky1, R E Kane, D P Jones, R E Galinsky, B Banner.   

Abstract

A 67-yr-old man with chronic cardiopulmonary disease exhibited severe hepatic and moderately severe renal injury after short-term ingestion of therapeutic doses of acetaminophen (1 to 3 gm/day for 3 days). Drug metabolism and other studies, performed 5 mo after recovery from the acute insult, indicated that the patient had decreased rates of hepatic metabolism of acetaminophen to its primary, nontoxic metabolites and decreased kidney function that was compromised further by acetaminophen ingestion. He also had abnormally low concentrations of hepatic and plasma reduced glutathione. Alcohol abuse and malnutrition could not be implicated in the pathogenesis of injury; rather it appeared that advancing age with chronic renal, cardiac and pulmonary insufficiency contributed to acetaminophen toxicity in this patient.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175135

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

Review 1.  Safe pharmacologic treatment strategies for osteoarthritis pain in African Americans with hypertension, and renal and cardiac disease.

Authors:  Jerry Johnson; Joan Weinryb
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

2.  High-performance metabolic profiling of plasma from seven mammalian species for simultaneous environmental chemical surveillance and bioeffect monitoring.

Authors:  Youngja H Park; Kichun Lee; Quinlyn A Soltow; Frederick H Strobel; Kenneth L Brigham; Richard E Parker; Mark E Wilson; Roy L Sutliff; Keith G Mansfield; Lynn M Wachtman; Thomas R Ziegler; Dean P Jones
Journal:  Toxicology       Date:  2012-03-01       Impact factor: 4.221

3.  Patterns of acetaminophen use exceeding 4 grams daily in a hospitalized population at a tertiary care center.

Authors:  Jesse M Civan; Victor Navarro; Steven K Herrine; Jeffrey M Riggio; Paul Adams; Simona Rossi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-01

Review 4.  Pharmacokinetic interactions between alcohol and other drugs.

Authors:  A G Fraser
Journal:  Clin Pharmacokinet       Date:  1997-08       Impact factor: 6.447

5.  Protective effect of pioglitazone, a PPARγ agonist against acetaminophen-induced hepatotoxicity in rats.

Authors:  Gaurav Gupta; Gopala Krishna; Dinesh Kumar Chellappan; Kumar Shiva Gubbiyappa; Mayuren Candasamy; Kamal Dua
Journal:  Mol Cell Biochem       Date:  2014-04-27       Impact factor: 3.396

6.  Abnormal serum transaminases following therapeutic doses of acetaminophen in the absence of known risk factors.

Authors:  D Kwan; W R Bartle; S E Walker
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

Review 7.  Does paracetamol potentiate the effects of oral anticoagulants?: a literature review.

Authors:  Isabelle Mahé; Charles Caulin; Jean-François Bergmann
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 8.  Pharmacology of morphine in obese patients: clinical implications.

Authors:  Célia Lloret Linares; Xavier Declèves; Jean Michel Oppert; Arnaud Basdevant; Karine Clement; Christophe Bardin; Jean Michel Scherrmann; Jean Pierre Lepine; Jean François Bergmann; Stéphane Mouly
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 9.  Long-term adverse effects of paracetamol - a review.

Authors:  J C McCrae; E E Morrison; I M MacIntyre; J W Dear; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2018-07-20       Impact factor: 4.335

Review 10.  Tolerability of paracetamol.

Authors:  Garry G Graham; Kieran F Scott; Richard O Day
Journal:  Drug Saf       Date:  2005       Impact factor: 5.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.